Send to

Choose Destination
Antioxidants (Basel). 2018 Jul 16;7(7). pii: E92. doi: 10.3390/antiox7070092.

Intravenous Vitamin C Administration Improved Blood Cell Counts and Health-Related Quality of Life of Patient with History of Relapsed Acute Myeloid Leukaemia.

Author information

Integrated Health Options Ltd., Auckland 1050, New Zealand.
Department of Pathology and Biomedical Science, University of Otago, Christchurch 8011, New Zealand.
Feedback Research Ltd., Auckland 1050, New Zealand.
Feedback Research Ltd., Auckland 1050, New Zealand.
Feedback Research Ltd., Auckland 1050, New Zealand.


A 52-year-old female presented to Integrated Health Options Clinic in October 2014 with a history of relapsed acute myeloid leukaemia (AML, diagnosed in 2009 and relapsed in 2014). Intravenous(IV) vitamin C therapy was initiated (in 2014) following completion of chemotherapy as an alternative to haematopoietic stem cell transplantation. IV vitamin C was administered twice weekly at a dose of 70 g/infusion. Within 4 weeks of initiation of IV vitamin C therapy, there was a dramatic improvement in the patient's blood indices with platelet cell counts increasing from 25 × 10⁸/L to 196 × 10⁸/L and white blood cell counts increasing from 0.29 × 10⁸/L to 4.0 × 10⁸/L, with further improvements observed over the next 18 months. Furthermore, there was a clear and sustained improvement in the patient's health-related quality of life scores assessed using a validated questionnaire. She has remained healthy and in complete remission until the present day. This case study highlights the benefits of IV vitamin C as a supportive therapy for previously relapsed AML.


AML; acute myeloid leukemia; intravenous vitamin C; leukemia; vitamin C

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center